Further processing options
Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinom...
Saved in:
Journal Title: | Annals of Oncology |
---|---|
Authors and Corporations: | , , , , , , , |
In: | Annals of Oncology, 22, 2011, 2, p. 295-300 |
Type of Resource: | E-Article |
Language: | English |
published: |
Elsevier BV
|
Subjects: |